Administration of meropenem for the treatment of ventilator-associated pneumonia

Ítems similars

• Susceptibility to carbapenems of Pseudomonas spp. isolated from patients with ventilator-associated pneumonia
  per: Zolotukhin, K, et al.
  Publicat: (2006)
• Meropenem administration by intermittent infusion versus continuous infusion for the treatment of nosocomial pneumonia
  per: Lorente, L, et al.
  Publicat: (2005)
• Epidemiology of ventilator-associated pneumonia in ICU patients
  per: Vakalos, A, et al.
  Publicat: (2009)
• Quality improvement: reducing ventilator-associated pneumonia
  per: Hawe, C, et al.
  Publicat: (2008)
• Cost Effectiveness of Ceftolozane/Tazobactam Compared with Meropenem for the Treatment of Patients with Ventilated Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
  per: Naik, Jaesh, et al.
  Publicat: (2021)